NCT06076967 Mindfulness Intervention for College Students With ADHD
| NCT ID | NCT06076967 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Alabama, Tuscaloosa |
| Condition | Attention Deficit Hyperactivity Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-09-15 |
| Primary Completion | 2026-05-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2023-09-15 with a primary completion date of 2026-05-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that commonly persists into adulthood and is associated with significant life impairments. The current study evaluates the feasibility, acceptability, and preliminary efficacy of a group-based mindfulness intervention for first-year college students with ADHD. If found to be feasible, acceptable, and efficacious, subsequent research will examine its impact on a larger scale to have a broader public health impact for college students with ADHD.
Eligibility Criteria
Inclusion Criteria: * First-semester college student with ADHD * Age 17-25 * Must meet criteria for ADHD * No major medical problems Exclusion Criteria: * Severe depression * Mania * Ongoing substance abuse * Personality disorder that may interfere with group delivery * Psychotic symptoms * Recent history of trauma * Unstable dosage of psychotropic medication
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06076967 clinical trial?
This trial is open to participants of all sexes, aged 17 Years or older, up to 25 Years, studying Attention Deficit Hyperactivity Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06076967 currently recruiting?
Yes, NCT06076967 is actively recruiting participants. Contact the research team at majarrett@ua.edu for enrollment information.
Where is the NCT06076967 trial being conducted?
This trial is being conducted at Tuscaloosa, United States, Spartanburg, United States.
Who is sponsoring the NCT06076967 clinical trial?
NCT06076967 is sponsored by University of Alabama, Tuscaloosa. The trial plans to enroll 100 participants.